Neuro-Oncology Reviews

Volume 25 Number 5
15 March 2023

Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 5, 15 March

Zeng J, Zeng XX.
Systems Medicine for Precise Targeting of Glioblastoma Systems Medicine Against Glioblastoma.
Mol Biotechnol. 2023 Mar 1:1–20∟. doi: 10.1007/s12033-023-00699-x∟. PMID: 36859639∟. Review. ˍ

*

Burko P, D'Amico G, Miltykh I, Scalia F, Conway de Macario E, Macario AJL, Giglia G, Cappello F, Caruso Bavisotto C.
Molecular Pathways Implicated in Radioresistance of Glioblastoma Multiforme: What Is the Role of Extracellular Vesicles?
Int J Mol Sci. 2023 Mar 2;24(5):4883∟. doi: 10.3390/ijms24054883∟. PMID: 36902314∟. Review. ˍ

Martin JA, Hart NH, Bradford N, Naumann F, Pinkham MB, Pinkham EP, Holland JJ.
Prevalence and management of sleep disturbance in adults with primary brain tumours and their caregivers: a systematic review.
J Neurooncol. 2023 Mar 2∟. doi: 10.1007/s11060-023-04270-1∟. PMID: 36864318∟. Review. ˍ

Xiaoxue T, Yinzhong W, Meng Q, Lu X, Lei J.
Diagnostic value of PET with different radiotracers and MRI for recurrent glioma: a Bayesian network meta-analysis.
BMJ Open. 2023 Mar 2;13(3):e062555∟. doi: 10.1136/bmjopen-2022-062555∟. PMID: 36863738∟. Meta-analysis. ˍ

Hirschler L, Sollmann N, Schmitz-Abecassis B, Pinto J, Arzanforoosh F, Barkhof F, Booth T, Calvo-Imirizaldu M, Cassia G, Chmelik M, Clement P, Ercan E, Fernández-Seara MA, Furtner J, Fuster-Garcia E, Grech-Sollars M, Guven NT, Hatay GH, Karami G, Keil VC, Kim M, Koekkoek JAF, Kukran S, Mancini L, Nechifor RE, Özcan A, Ozturk-Isik E, Piskin S, Schmainda K, Svensson SF, Tseng CH, Unnikrishnan S, Vos F, Warnert E, Zhao MY, Jancalek R, Nunes T, Emblem KE, Smits M, Petr J, Hangel G.
Advanced MR Techniques for Preoperative Glioma Characterization: Part 1.
J Magn Reson Imaging. 2023 Mar 3∟. doi: 10.1002/jmri.28662∟. PMID: 36866773∟. Review. ˍ

Jovanovich N, Habib A, Hameed NF, Edwards L, Zinn PO.
Applications and current challenges of chimeric antigen receptor T cells in treating high-grade gliomas in adult and pediatric populations.
Immunotherapy. 2023 Mar 6;15(5):383-396∟. doi: 10.2217/imt-2022-0200∟. PMID: 36876438∟. Review˰ ˍ

*

Mohapatra S, Cafiero J, Kashfi K, Mehta P, Banerjee P.
Why Don't the Mutant Cells That Evade DNA Repair Cause Cancer More Frequently? Importance of the Innate Immune System in the Tumor Microenvironment.
Int J Mol Sci. 2023 Mar 6;24(5):5026∟. doi: 10.3390/ijms24055026∟. PMID: 36902456∟. Review. ˍ

Sait SF, Giantini-Larsen AM, Tringale KR, Souweidane MM, Karajannis MA.
Treatment of Pediatric Low-Grade Gliomas.
Curr Neurol Neurosci Rep. 2023 Mar 7∟. doi: 10.1007/s11910-023-01257-3∟. PMID: 36881254∟. Review˰ ˍ

Villa GR, Chiocca EA.
The Role of Long Noncoding RNAs in Glioblastoma: What the Neurosurgeon Should Know.
Neurosurgery. 2023 Mar 7∟. doi: 10.1227/neu.0000000000002449∟. PMID: 36880757∟. Review˰ ˍ

Ardizzone A, Basilotta R, Filippone A, Crupi L, Lanza M, Lombardo SP, Colarossi C, Sciacca D, Cuzzocrea S, Esposito E, Campolo M.
Recent Emerging Immunological Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting Immunotherapies.
Cells. 2023 Mar 8;12(6):841∟. doi: 10.3390/cells12060841∟. PMID: 36980182∟. Review. ˍ

Viaene AN.
Pediatric brain tumors: A neuropathologist's approach to the integrated diagnosis.
Front Pediatr. 2023 Mar 8;11:1143363∟. doi: 10.3389/fped.2023.1143363∟. PMID: 36969278∟. Review. ˍ

Wu L, Chai R, Lin Z, Wu R, Yao D, Jiang T, Wang Q.
Evolution-driven crosstalk between glioblastoma and the tumor microenvironment.
Cancer Biol Med. 2023 Mar 8:j.issn.2095-3941.2022.0771∟. doi: 10.20892/j.issn.2095-3941.2022.0771∟. PMID: 36880534∟. Perspective. ˍ

Zhang S, Ni Q.
Prognostic role of the pretreatment systemic immune-inflammation index in patients with glioma: A meta-analysis.
Front Neurol. 2023 Mar 8;14:1094364∟. doi: 10.3389/fneur.2023.1094364∟. PMID: 36970508∟. Meta-analysis. ˍ

Orzan OA, Giurcăneanu C, Dima B, Dima MB, Ion A, Bălăceanu B, Nițipir C, Tudose I, Nicolae CA, Dorobanțu AM.
Cutaneous Melanoma and Glioblastoma Multiforme Association-Case Presentation and Literature Review.
Diagnostics (Basel). 2023 Mar 9;13(6):1046∟. doi: 10.3390/diagnostics13061046∟. PMID: 36980355∟. Case report, Review. ˍ

Dellaretti M, Melo MT, Faraj de Lima FB, Guazzelli S, Costa BBR, Pereira PSS, Torres RE.
Fluorescein-guided surgery for malignant gliomas.
World Neurosurg. 2023 Mar 10:S1878-8750(23)00294-2∟. doi: 10.1016/j.wneu.2023.02.144∟. PMID: 36906086∟. Review, Video article˰ ˍ

Duffau H.
Oncological and functional neurosurgery: Perspectives for the decade regarding diffuse gliomas.
Rev Neurol (Paris). 2023 Mar 10:S0035-3787(23)00861-5∟. doi: 10.1016/j.neurol.2023.01.724∟. PMID: 36907710∟. Review˰ ˍ

Huang X, Shi S, Wang H, Zhao T, Wang Y, Huang S, Su Y, Zhao C, Yang M.
Advances in antibody-based drugs and their delivery through the blood-brain barrier for targeted therapy and immunotherapy of gliomas.
Int Immunopharmacol. 2023 Mar 10;117:109990∟. doi: 10.1016/j.intimp.2023.109990∟. PMID: 37012874∟. Review˰ ˍ

*

Natale G, Fini E, Calabrò PF, Carli M, Scarselli M, Bocci G.
Valproate and lithium: Old drugs for new pharmacological approaches in brain tumors?
Cancer Lett. 2023 Mar 11;560:216125∟. doi: 10.1016/j.canlet.2023.216125∟. PMID: 36914086∟. Review˰ ˍ

Cruz N, Herculano-Carvalho M, Roque D, Faria CC, Cascão R, Ferreira HA, Reis CP, Matela N.
Highlighted Advances in Therapies for Difficult-To-Treat Brain Tumours Such as Glioblastoma.
Pharmaceutics. 2023 Mar 13;15(3):928∟. doi: 10.3390/pharmaceutics15030928∟. PMID: 36986790∟. Review. ˍ

Hangel G, Schmitz-Abecassis B, Sollmann N, Pinto J, Arzanforoosh F, Barkhof F, Booth T, Calvo-Imirizaldu M, Cassia G, Chmelik M, Clement P, Ercan E, Fernández-Seara MA, Furtner J, Fuster-Garcia E, Grech-Sollars M, Guven NT, Hatay GH, Karami G, Keil VC, Kim M, Koekkoek JAF, Kukran S, Mancini L, Nechifor RE, Özcan A, Ozturk-Isik E, Piskin S, Schmainda KM, Svensson SF, Tseng CH, Unnikrishnan S, Vos F, Warnert E, Zhao MY, Jancalek R, Nunes T, Hirschler L, Smits M, Petr J, Emblem KE.
Advanced MR Techniques for Preoperative Glioma Characterization: Part 2.
J Magn Reson Imaging. 2023 Mar 13∟. doi: 10.1002/jmri.28663∟. PMID: 36912262∟. Review. ˍ

*

Reiter RJ, Sharma R, Cucielo MS, Tan DX, Rosales-Corral S, Gancitano G, de Almeida Chuffa LG.
Brain washing and neural health: role of age, sleep, and the cerebrospinal fluid melatonin rhythm.
Cell Mol Life Sci. 2023 Mar 14;80(4):88∟. doi: 10.1007/s00018-023-04736-5? PMID: 36917314∟. Review˰ ˍ

Asija S, Chatterjee A, Goda JS, Yadav S, Chekuri G, Purwar R.
Oncolytic immunovirotherapy for high-grade gliomas: A novel and an evolving therapeutic option.
Front Immunol. 2023 Mar 15;14:1118246∟. doi: 10.3389/fimmu.2023.1118246∟. PMID: 37006286∟. Review. ˍ

Casciati A, Mancuso M, Vitali R, Pazzaglia S.
Gut-brain axis: does intestinal inflammation affect hippocampal neurogenesis and medulloblastoma development?
Neural Regen Res. 2023 Mar 15;18(11):2381-2382∟. doi: 10.4103/1673-5374.371353∟. PMID: 37282458∟. Perspective. ˍ

Wach J, Vychopen M, Kühnapfel A, Seidel C, Güresir E.
A Systematic Review and Meta-Analysis of Supramarginal Resection versus Gross Total Resection in Glioblastoma: Can We Enhance Progression-Free Survival Time and Preserve Postoperative Safety?
Cancers (Basel). 2023 Mar 15;15(6):1772∟. doi: 10.3390/cancers15061772∟. PMID: 36980659∟. Review. ˍ